Loading...
Loading...
By MBN Staff - Mon, 01/19/2026 - 09:01
Novo Nordisk México appoints Patricia Field as Director General to strengthen innovation, access to care, and its chronic disease strategy.
https://mexicobusiness.news/tag/obesity
More Health
By Sofía Garduño - Fri, 01/16/2026 - 10:14
Novo Nordisk launches Wegovy pill in the United States, introducing the first oral GLP-1 option for weight management.
By MBN Staff - Fri, 11/21/2025 - 14:11
A new global review warns that ultra-processed foods are driving a major shift in global diets and increasing the risk of chronic diseases.
By Sofía Garduño - Fri, 11/21/2025 - 12:32
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By Sofía Garduño - Fri, 11/21/2025 - 11:55
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By MBN Staff - Tue, 11/18/2025 - 11:49
Mexico expands its global role in food policy and chronic disease prevention through a new international hub led by the INSP and CINyS.
By Sofía Garduño - Thu, 11/06/2025 - 16:03
Pfizer and Novo Nordisk escalate legal battle over Metsera amid rising competition in the obesity treatment market.
By MBN Staff - Fri, 10/17/2025 - 13:43
The Chamber of Deputies approved reforms to increase IEPS rates on sugary beverages and tobacco.
By Sofía Garduño - Fri, 10/17/2025 - 10:33
Mexico will raise its sugar-sweetened beverage tax in 2026 to reduce consumption and fund nationwide preventive health programs.
By MBN Staff - Mon, 09/29/2025 - 19:43
The Ministry of Health and UAM have initiated a strategic partnership to promote food sovereignty and address national nutritional challenges.
